Critical care medicine · 2025
Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure.
СтатьяНаблюдательное исследованиеМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Labar Amy S, Ulrich Bryan C, Lovelace Tyler C, Bain William G, Shah Faraaz A, White Emma B, Abe Elizabeth A, Giacona Francesca, Alba George A, Thompson B Taylor, Schmidt Eric P, Zuchelkowski Benjamin E, Evankovich John W, Yang Haopu, Ramanan Raj, Murray Holt, Haidar Ghady, Snyder Mark E, Qin Shulin, Wang Xiahong, Zhang Yingze, Nouraie Seyed M, Dela Cruz Charles, Turnquist Hēth R, Ray Prabir, Ray Anuradha, Methé Barbara, Benos Panayiotis V, Morris Alison, McVerry Bryan J, Alladina Jehan, Kitsios Georgios D
Аннотация
OBJECTIVES: Soluble ST2 (sST2), a decoy receptor for the alarmin interleukin-33 (IL-33), has been implicated in adverse clinical outcomes in acute respiratory failure (ARF). We evaluated sST2 distribution across diverse cohorts of patients with different etiologies of ARF, compared plasma and lower respiratory tract (LRT) concentrations, and examined associations with individual organ dysfunction, biological subphenotypes, and outcomes.
DESIGN: Observational study.
SETTING: Multicenter cohorts of ARF patients.
PATIENTS: A total of 1432 ARF patients, including 863 non-COVID and 569 COVID-19 cases, from five cohorts.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: sST2 levels were measured in plasma and LRT specimens (when available) and analyzed for associations with ARF etiology, severity, organ dysfunction, systemic host response, subphenotypes, and 30-day mortality. Plasma sST2 levels were higher in non-COVID ARF patients compared with COVID-19 patients ( p < 0.05) and were markedly elevated compared with LRT levels (> 19-fold), with weak intercompartmental correlation. Elevated plasma sST2 levels were associated with extrapulmonary organ dysfunction and a hyperinflammatory ARF subphenotype but not with respiratory indices, including hypoxemia. Plasma sST2 independently predicted 30-day mortality in pooled cohort data, adjusted for age, sex, and illness severity. In longitudinal measurements, nonsurvivors had persistently elevated plasma sST2 levels in the first 2 weeks of critical illness compared with survivors.
CONCLUSIONS: Plasma sST2 levels independently predict outcomes in ARF and are strongly associated with extrapulmonary organ dysfunction. The weak correlation between plasma and LRT sST2 levels suggests a predominantly systemic source. These findings highlight the potential of the IL-33/ST2 axis as a therapeutic target and warrant further investigation into its role in multiple organ dysfunction in ARF.
DESIGN: Observational study.
SETTING: Multicenter cohorts of ARF patients.
PATIENTS: A total of 1432 ARF patients, including 863 non-COVID and 569 COVID-19 cases, from five cohorts.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: sST2 levels were measured in plasma and LRT specimens (when available) and analyzed for associations with ARF etiology, severity, organ dysfunction, systemic host response, subphenotypes, and 30-day mortality. Plasma sST2 levels were higher in non-COVID ARF patients compared with COVID-19 patients ( p < 0.05) and were markedly elevated compared with LRT levels (> 19-fold), with weak intercompartmental correlation. Elevated plasma sST2 levels were associated with extrapulmonary organ dysfunction and a hyperinflammatory ARF subphenotype but not with respiratory indices, including hypoxemia. Plasma sST2 independently predicted 30-day mortality in pooled cohort data, adjusted for age, sex, and illness severity. In longitudinal measurements, nonsurvivors had persistently elevated plasma sST2 levels in the first 2 weeks of critical illness compared with survivors.
CONCLUSIONS: Plasma sST2 levels independently predict outcomes in ARF and are strongly associated with extrapulmonary organ dysfunction. The weak correlation between plasma and LRT sST2 levels suggests a predominantly systemic source. These findings highlight the potential of the IL-33/ST2 axis as a therapeutic target and warrant further investigation into its role in multiple organ dysfunction in ARF.